Work

Pd19-06 48 Month Follow up of Results of the Pcm-204 Phase 2b Trial of Partial-gland Ablation for Men With Intermediate-risk Prostate Cancer With Padeliporfin (wst11 or Tookad) Vascular-targeted Photodynamic Therapy